Multiple molecular mechanisms for multidrug resistance transporters

Nature

Volumn 446, Issue 7137, 2007, Pages 749-757

  Higgins, Christopher F ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BETA LACTAM ANTIBIOTIC; DOXORUBICIN; ETHIDIUM; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PROTEIN; RESISTANCE NODULATION DIVISION PROTEIN; RHODAMINE 6G; SMALL MULTIDRUG RESISTANCE PROTEIN; TETRAPHENYLPHOSPHONIUM; UNCLASSIFIED DRUG;

CYTOLOGY; DRUG RESISTANCE; HEALTH CARE; PROTEIN; TOXIC SUBSTANCE;

ALPHA HELIX; ANTIBIOTIC RESISTANCE; CANCER RESISTANCE; DRUG PROTEIN BINDING; ENZYME SUBSTRATE; GENE OVEREXPRESSION; HYDROPHOBICITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; X RAY ANALYSIS;

MAMMALIA;

EID: 34147214716     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05630     Document Type: Review

References (77)

1. Schinkel, A. H., Wagenaar, E., Mol, C. A. & van Deemter, L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97, 2517-2524 (1996).
2. Saier, M. H. & Paulsen, I. T. Phylogeny of multidrug transporters. Semin. Cell Dev. Biol. 12, 205-213 (2001).
3. Higgins, C. F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8, 67-113 (1992).
4. Juliano, R. L. & Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 152-162 (1976).
5. Gottesman, M. M. Fojo, T. & Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nature Rev. Cancer 2, 48-58 (2001).
6. Holland, I. B., Cole, S. P. C., Kuchler, K. & Higgins, C. F. (eds) ABC Proteins: from Bacteria to Man (Academic, London, 2003).
7. van Veen, H. W. et al. A bacterial antibiotic resistance gene that complements the human multidrug resistance P-glycoprotein gene. Nature 391, 291-295 (1998).
8. Higgins, C. F. et al. A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature 323, 448-450 (1986).
9. Rosenberg, M. F., Callaghan, R., Ford, R. C. & Higgins, C. F. Structure of the multidrug-resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy. J. Biol. Chem. 272, 10685-10694 (1997).
10. Rosenberg, M. F. et al. Repacking of the transmembrane domains of P-glycoprotein, during the transport ATPase cycle. EMBO J. 20, 5615-5625 (2001).
11. Rosenberg, M. F., Kamis, A. B., Callaghan, R., Higgins, C. F. & Ford, R. C. Three-imensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding. J. Biol. Chem. 278, 8294-8299 (2003).
12. Rosenberg, M. F., Callaghan, R., Modok, S., Higgins, C. F. & Ford, R. C. Three-dimensional structure of P-glycoprotein: the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state. J. Biol. Chem. 280, 2857-2862 (2005).
13. Dawson, R. J. P. & Locher, K. P. Structure of a bacterial multidrug ABC transporter. Nature 443, 180-185 (2006).
14. Loo, T. W. & Clarke, D. M. The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis. J. Biol. Chem. 275, 5253-5256 (2000).
15. Stenham, D. R. et al. An atomic detail model for the human ATP-binding cassette transporter, P-glycoprotein, derived from disulphide cross-linking and homology modelling. FASEB J. 17, 2287-2289 (2003).
16. Smith, P. C. et al. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol. Cell 10, 139-149 (2002).
17. Locher, K. P., Lee, A. T. & Rees, D. C. The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296, 1091-1098 (2002).
18. Pinkett, H. W., Lee, A. T., Lum, P., Locher, K. P. & Rees, D. C. An inward facing conformation of a putative metal-chelate-type ABC transporter. Science 315, 373-377 (2007); published online 7 December 2006.
19. Chang, G. et al. Retraction. Science 314, 1875 (2006).
20. Zolnerciks, J. K., Wooding, C. & Linton, K. J. In vivo evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. J. Biol. Chem. (submitted).
21. Higgins, C. F. & Linton, K. J. The ATP switch model for ABC transporters. Nature Struct. Mol. Biol. 11, 918-926 (2004).
22. Dong, J., Yang, G. & Mchaourab, H. S. Structural basis for energy transduction in the transport cycle of MsbA. Science 308, 1023-1028 (2005).
23. Dey, S., Ramachandra, M., Pastan, I., Gottesman, M. M. & Ambudkar, S. V. Evidence for two non-identical drug-interaction sites in the human P-glycoprotein. Proc. Natl Acad. Sci. USA 94, 10594-10599 (1997).
24. Martin, C. et al. Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis. Biochemistry 39, 11901-11906 (2000).
25. Martin, C., Higgins, C. F. & Callaghan, R. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein. Biochemistry 40, 15733-15742 (2001).
26. Payen, L. F., Gao, M., Westlake, C. J., Cole, S. P. C. & Deeley, R. G. Role of carboxylate residues adjacent to the conserved core walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1). J. Biol. Chem. 278, 38537-38547 (2003).
27. van Veen, H. W., Margolles, A., Muller, M., Higgins, C. F. & Konings, W. N. The homodimeric ATP binding cassette transporter LmrA mediates multidrug resistance by a two-site (two-cylinder engine) mechanism. EMBO J. 19, 2503-2514 (2000).
28. Vergani, P., Lockless, S. W., Nairn, A. C. & Gadsby, D. C. CFTR channel opening by ATP-driven tight dimerization of its nucleotide binding domains. Nature 433, 876-880 (2005).
29. Higgins, C. F. & Gottesman, M. M. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17, 18-21 (1992).
30. Bolhuis, H. et al. Multidrug resistance in Lactococcus lactis: evidence for ATPdependent drug extrusion from the inner leaflet of the cytoplasmic membrane. EMBO J. 15, 4239-4245 (1996).
31. Loo, T. W. & Clarke, D. M. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J. Membr. Biol. 206, 173-185 (2005).
32. Martin, C. et al. Communication between multiple drug binding sites on P-glycoprotein. Mol. Pharmacol. 58, 624-632 (2000).
33. Shapiro, A. B. & Ling, V. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250, 130-137 (1997).
34. Zelcer, N. et al. Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ABCC2). J. Biol. Chem. 278, 23538-23544 (2003).
35. Lugo, M. R. & Sharom, F. J. Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs. Biochemistry 44, 14020-14029 (2005).
36. Ko, D. C., Gordon, M. D., Jin, J. Y. & Scott, M. P. Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. Mol. Biol. Cell 12, 601-614 (2001).
37. Ma, Y. et al. Hedgehog-medicated patterning of the mammalian embryo requires transporter-like function of dispatched. Cell 111, 63-75 (2002).
38. Zgurskaya, H. I. & Nikaido, H. Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc. Natl Acad. Sci. USA 96, 7190-7195 (1999).
39. Murakami, S., Nakashima, R., Yamashita, E. & Yamaguchi, A. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419, 587-593 (2002).
40. Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T. & Yamaguchi, A. Crystal structure of a multidrug transporter reveals a functionally rotating mechanism. Nature 443, 173-179 (2006).
41. Yu, E. W., McDermott, G., Zgurskaya, H. I., Nikaido, H. & Koshland, D. E. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300, 976-980 (2003).
42. Seeger, M. A. et al. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 313, 1295-1298 (2006).
43. Koronakis, V., Sharff, A., Koronakis, E., Luisi, B. & Hughes, C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405, 914-919 (2000).
44. Aires, J. R. & Nikaido, H. Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. Bacteriol. 187, 1923-1929 (2005).
45. Schuldiner, S., Lebendiker, M. & Yerushalmi, H. EmrE, the smallest ion-coupled transporter, provides a unique paradigm for structure-function studies. J. Exp. Biol. 200, 335-341 (1997).
46. Ubarretxena-Belandia, I., Baldwin, J. M., Schuldiner, S. & Tate, C. G. Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer. EMBO J. 22, 6175-6181 (2003).
47. Sharoni, M., Steiner-Mordoch, S. & Schuldiner, S. Exploring the binding domain of EmrE, the smallest multidrug transporter. J. Biol. Chem. 280, 32849-32855 (2005).
48. Soskine, M., Mark, S., Tayer, N., Mizrachi, R. & Schuldiner, S. On parallel and antiparallel topology of a homodimeric multidrug transporter. J. Biol. Chem. 281, 36205-36212 (2006).
49. Rapp, M., Granseth, E., Seppala, S. & von Heijne, G. Identification and evolution of dual-topology proteins. Nature Struct. Mol. Biol. 13, 112-116 (2006).
50. + and substrate fluxes based on 'time-sharing' of a common binding site. Biochemistry 39, 14711-14719 (2000).
51. Abramson, J. et al. Structure and mechanisms of the lactose permease of Escherichia coli. Science 301, 610-615 (2003).
52. Huang, Y., Lemieux, M. J., Song, J., Auer, M. & Wang, D. N. Structure and mechanisms of the glycerol-3-phosphate transporter from Escherichia coli. Science 301, 616-620 (2003).
53. Yin, Y., He, X., Szewczyk, P., Nguyen, T. & Chang, G. Structure of the multidrug transporter EmrD from Escherichia coli. Science 312, 741-744 (2006).
54. Adler, J. & Bibi, J. Promiscuity in the geometry of electrostatic interactions between the Escherichia coli multidrug resistance transporter MdfA and cationic substrates. J. Biol. Chem. 280, 2721-2729 (2005).
55. Mazurkiewicz, P., Driessen, A. J. & Konings, W. N. Energetics of wild type and mutant multidrug resistance secondary transporter LmrP of Lactococcus lactis. Biochim. Biophys. Acta 1658, 252-261 (2004).
56. Putman, M., Koole, L. A., van Veen, H. W. & Konings, W. N. The secondary multidrug transporter LmrP contains multiple drug interaction sites. Biochemistry 38, 13900-13905 (1999).
57. Lewinson, O., Padan, E. & Bibi, E. Alkalitolerance: a biological function for a multidrug transporter in pH homeostasis. Proc. Natl Acad. Sci. USA 101, 14073-14078 (2004).
58. Abramson, J., Iwata, S. & Kaback, H. R. Lactose permease as a paradigm for membrane transport proteins (Review). Mol. Membr. Biol. 21, 227-236 (2004).
59. Zheleznova, E. E., Markham, P. N., Neyfakh, A. A. & Brennan, R. G. Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell 96, 353-362 (1999).
60. Vázquez-Laslop, N., Markham, P. N. & Neyfakh, A. A. Mechanisms of ligand recognition by BmrR, the multidrug-responding transcriptional regulator: mutational analysis of the ligand binding site. Biochemistry 38, 16925-16931 (1999).
61. Schumacher, M. A. et al. Structural mechanisms of QacR induction and multidrug recognition. Science 294, 2158-2163 (2001).
62. Schumacher, M. A., Miller, M. C. & Brennan, R. G. Structural mechanisms of the simultaneous binding of two drugs to a multidrug-binding protein. EMBO J. 23, 2923-2930 (2004).
63. Neyfakh, A. A. Mystery of multidrug transporters: the answer can be simple. Mol. Microbiol. 44, 1123-1130 (2002).
64. Tame, J. R. H. et al. The structural basis of sequence-independent peptide binding by OppA protein. Science 264, 1578-1581 (1994).
65. Cupp-Vickery, J., Anderson, R. & Hatziris, Z. Crystal structures of ligand complexes of P450eryF exhibiting homotropic competition. Proc. Natl Acad. Sci. USA 97, 3050-3055 (2000).
66. Watkins, R. E. et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292, 2329-2333 (2001).
67. Ramoni, R. et al. The insect attractant 1-octen-3-ol is the natural ligand of bovine odorant-binding protein. J. Biol. Chem. 276, 7150-7155 (2001).
68. Chang, G. & Roth, C. B. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science 293, 1793-1800 (2001).
69. Ma, C. & Chang, G. Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli. Proc. Natl Acad. Sci. USA 101, 2852-2857 (2004).
70. Mitchell, P. A general theory for membrane transport from studies of bacteria. Nature 180, 134-136 (1957).
71. Smit, J. J. M. et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451-462 (1993).
72. Stein, W. D., Cardarelli, C., Pastan, I. & Gottesman, M. M. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Mol. Pharmacol. 45, 763-772 (1994).
73. Buchler, M. et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMRP, reveals a novel conjugate export pump deficient in the hyperbilirubinemic mutant rats. J. Biol. Chem. 271, 15091-15098 (1996).
74. Ahmed, M. et al. Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated. J. Bacteriol. 177, 3904-3910 (1995).
75. Lewinson, O. & Bibi, E. Evidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA. Biochemistry 40, 12612-12618 (2001).
76. r 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res. 58, 5130-5136 (1998).
77. Rius, M., Mies, A. J., Hummel-Eisenbeiss, J., Jedlitschky, G. & Keppler, D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38, 374-384 (2003).